Opaleye Management Inc. Larimar Therapeutics, Inc. Transaction History

Opaleye Management Inc.

$418 Million
Q2 2025

A detailed history of Opaleye Management Inc. transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 4,110,000 shares of LRMR stock, worth $19.4 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares

4,110,000

Previous 4,110,000 -0.0%

Holding current value

$19.4 Million

Previous $11.9 Million -0.0%

% of portfolio

2.84%

Previous 2.84%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.71 - $3.25 $3.76 Million - $7.14 Million	2,195,923 Added 114.72%	4,110,000 $11.9 Million
Q1 2025 May 15, 2025	BUY	$2.15 - $4.18 $4.12 Million - $8 Million	1,914,077 New	1,914,077 $4.12 Million
Q1 2024 May 15, 2024	SELL	$4.2 - $13.28 $1.89 Million - $5.96 Million	-449,087 Reduced 72.03%	174,413 $1.32 Million
Q4 2023 Feb 14, 2024	SELL	$2.35 - $4.71 $528,750 - $1.06 Million	-225,000 Reduced 26.52%	623,500 $2.84 Million
Q3 2023 Nov 14, 2023	SELL	$3.08 - $4.49 $1.67 Million - $2.43 Million	-541,500 Reduced 38.96%	848,500 $3.35 Million
Q2 2023 Aug 14, 2023	SELL	$3.13 - $5.27 $34,430 - $57,969	-11,000 Reduced 0.79%	1,390,000 $4.35 Million
Q1 2023 May 12, 2023	SELL	$4.0 - $6.68 $636,000 - $1.06 Million	-159,000 Reduced 10.19%	1,401,000 $6.35 Million
Q4 2022 Feb 10, 2023	SELL	$2.73 - $5.08 $277,870 - $517,062	-101,784 Reduced 6.12%	1,560,000 $6.44 Million
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $1.12 Million - $2.65 Million	728,970 Added 78.15%	1,661,784 $5.32 Million
Q2 2022 Aug 15, 2022	SELL	$1.9 - $3.98 $20,687 - $43,334	-10,888 Reduced 1.15%	932,814 $1.83 Million
Q1 2022 May 16, 2022	BUY	$3.65 - $10.84 $219,365 - $651,484	60,100 Added 6.8%	943,702 $3.82 Million
Q4 2021 Feb 14, 2022	BUY	$8.86 - $13.47 $450,043 - $684,208	50,795 Added 6.1%	883,602 $9.53 Million
Q3 2021 Nov 16, 2021	BUY	$9.61 - $15.11 $1.01 Million - $1.59 Million	105,007 Added 14.43%	832,807 $9.6 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $15.2 $5.82 Million - $11.1 Million	727,800 New	727,800 $7.15 Million

Others Institutions Holding LRMR

# of Institutions

127

Shares Held

65.9M

Call Options Held

4.83M

Put Options Held

83.7K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $205M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Larimar Therapeutics, Inc. Transaction History